Cargando…

Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery

OBJECTIVE: To identify the predictive factors for responders to tolvaptan, a novel vasopressin type 2 receptor antagonist for fluid management after cardiovascular surgery. METHODS: Between January 2013 and May 2014, 113 patients were treated with tolvaptan for fluid management after cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kido, Takashi, Nishi, Hiroyuki, Toda, Koichi, Ueno, Takayoshi, Kuratani, Toru, Sakaki, Masayuki, Takahashi, Toshiki, Sawa, Yoshiki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285430/ https://www.ncbi.nlm.nih.gov/pubmed/27645146 http://dx.doi.org/10.1007/s11748-016-0712-6

Ejemplares similares

The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster
por: Kido, Takashi, et al.
Publicado: (2018)

First Transcatheter Aortic Valve Implantation via Carotid Artery Performed in Japan
por: Misumi, Yusuke, et al.
Publicado: (2018)

Adipose-derived mesenchymal stem cells preserve cardiac function via ANT-1 in dilated cardiomyopathy hamster model
por: Mori, Daisuke, et al.
Publicado: (2021)

Redo surgery after transcatheter aortic valve replacement with a balloon-expandable valve
por: Nakazato, Taro, et al.
Publicado: (2020)

Impact of microRNA Expression in Human Atrial Tissue in Patients with Atrial Fibrillation Undergoing Cardiac Surgery
por: Nishi, Hiroyuki, et al.
Publicado: (2013)

New cell delivery system CellSaic with adipose-derived stromal cells promotes functional angiogenesis in critical limb ischemia model mice
por: Tanioka, Hideki, et al.
Publicado: (2021)

Autologous skeletal myoblast patch implantation prevents the deterioration of myocardial ischemia and right heart dysfunction in a pressure-overloaded right heart porcine model
por: Araki, Kanta, et al.
Publicado: (2021)

Pioglitazone strengthen therapeutic effect of adipose-derived regenerative cells against ischemic cardiomyopathy through enhanced expression of adiponectin and modulation of macrophage phenotype
por: Mori, Daisuke, et al.
Publicado: (2019)

Impact of tricuspid regurgitation on late right ventricular failure in left ventricular assist device patients ~can prophylactic tricuspid annuloplasty prevent late right ventricular failure? ~
por: Nakazato, Taro, et al.
Publicado: (2021)

Effects of Low-Dose Tolvaptan for Fluid Management After Cardiovascular Surgery
por: Matsuda, Yasuhiro, et al.
Publicado: (2022)

Mitochondrial Transfer Induced by Adipose-Derived Mesenchymal Stem Cell Transplantation Improves Cardiac Function in Rat Models of Ischemic Cardiomyopathy
por: Mori, Daisuke, et al.
Publicado: (2023)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Salvage surgery for stage IVa thymic carcinoma combined with aortic arch resection – case report
por: Yamato, Hiroyuki, et al.
Publicado: (2020)

Innovative therapeutic strategy using prostaglandin I(2) agonist (ONO1301) combined with nano drug delivery system for pulmonary arterial hypertension
por: Kanaya, Tomomitsu, et al.
Publicado: (2021)

Simultaneous Aortic Valve-in-Valve and Ascending Stent Grafting for Prosthetic Valve Stenosis and Ascending Flap
por: Yamashita, Yoshiyuki, et al.
Publicado: (2020)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Early and midterm results of thoracic endovascular aortic repair using a branched endograft for aortic arch pathologies: A retrospective single-center study
por: Kudo, Tomoaki, et al.
Publicado: (2020)

Effectiveness and Minimal-Invasiveness of Zone 0 Landing Thoracic Endovascular Aortic Repair Using Branched Endograft
por: Kudo, Tomoaki, et al.
Publicado: (2022)

Assessment of the Effectiveness of Zone 1-Landing Hybrid TEVAR by Comparing Its Outcomes with Those of Zone 2-Landing Hybrid TEVAR
por: Kudo, Tomoaki, et al.
Publicado: (2023)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017)

Tolvaptan Reduces Extracellular Fluid per Amount of Body Fluid Reduction Less Markedly than Conventional Diuretics
por: Iwatani, Hirotsugu, et al.
Publicado: (2022)

High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells
por: Goto, Takasumi, et al.
Publicado: (2020)

Impact of complete revascularization in coronary artery bypass grafting for ischemic cardiomyopathy
por: Nakae, Masaro, et al.
Publicado: (2023)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Outcomes of Redo Transcatheter Aortic Valve Implantation for Structural Valve Degeneration of Transcatheter Aortic Valve
por: Tsuda, Masaki, et al.
Publicado: (2019)

Efficacy of tolvaptan for fluid management after cardiovascular surgery: A systematic review and meta-analysis of randomized control trials
por: Chen, Huiling, et al.
Publicado: (2020)

Detrimental effects of elevated transpulmonary gradient on outcomes following restrictive mitral annuloplasty in patients with pre-existing pulmonary hypertension
por: Kainuma, Satoshi, et al.
Publicado: (2021)

Secondary abdominal compartment syndrome required decompression laparotomy during minimally invasive mitral valve repair
por: Nishi, Hiroyuki, et al.
Publicado: (2016)

Tolvaptan for Fluid Management in Living Donor Liver Transplant Recipients
por: Imai, Shunichi, et al.
Publicado: (2018)

Long-term outcomes of autologous skeletal myoblast cell-sheet transplantation for end-stage ischemic cardiomyopathy
por: Kainuma, Satoshi, et al.
Publicado: (2021)

Restrictive mitral annuloplasty with or without coronary artery bypass grafting in ischemic mitral regurgitation
por: Kainuma, Satoshi, et al.
Publicado: (2020)

Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
por: Suzuki, Satoshi, et al.
Publicado: (2014)

Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery
por: Horie, Kotaro, et al.
Publicado: (2023)

Successful surgery localized to the infected lesion as diagnosed by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for extended-aortic prosthetic graft infection
por: Goto, Takasumi, et al.
Publicado: (2019)

Evaluation of complications of administration for tolvaptan after fluid resuscitation in critical care
por: Arimoto, H, et al.
Publicado: (2015)

Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide
por: Suzuki, Satoshi, et al.
Publicado: (2013)

Redo coronary bypass grafting for congenital left main coronary atresia: a case report
por: Yajima, Shin, et al.
Publicado: (2017)

Effectiveness of tolvaptan monotherapy and low-dose furosemide/tolvaptan combination therapy for hepatoprotection and diuresis in a rat cirrhotic model
por: Tanabe, Norikazu, et al.
Publicado: (2017)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

Successful treatment of graft-duodenal fistula after renovisceral debranching thoracic endovascular aortic repair with limited graft resection based on (18)F-fluorodeoxyglucose positron emission tomography with computed tomography
por: Matsumoto, Ryota, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q77rs7ppa7p3dfn6ms2hnkdf8g